Both in Pharmaceuticals
Canopy Growth vs Arcturus Therapeutics Holdings
Over the past year CGC returned −41.1% and ARCT returned −27.1%; their daily moves had a correlation of 0.16.
CGC −41.1% ARCT −27.1%Growth of $1, one year, split-adjusted
| Metric | CGC | ARCT |
|---|---|---|
| Price | $0.9251 | $13.70 |
| Market cap | $391.4M | $389.4M |
| Today | −0.03% | −5.26% |
| 1 month | −7.4% | −9.8% |
| 6 months | +8.0% | +98.6% |
| Year to date | −18.9% | +123.5% |
| 1 year | −31.0% | −38.2% |
| Revenue growth (YoY) | +7.8% | −89.5% |
| Gross margin | 27.4% | 100.0% |
| Net margin | −18.0% | −803.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.6× | 13.3× |
| Net cash | $67.9M | $191.5M |
| Dividend yield | — | — |
| Volatility (60d) | 33.1% | 99.0% |
| Short % of float | 6.6% | 24.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).